Brokerages Set CytomX Therapeutics, Inc. (NASDAQ:CTMX) Target Price at $5.77
Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six research firms that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1-year target price […]
Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six research firms that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1-year target price […]
